We are live on ! Find out more
HQL

abrdn Life Sciences Investors
HQL

41 hedge funds and large institutions have $47.6M invested in abrdn Life Sciences Investors in 2017 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 17 increasing their positions, 13 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

31% more repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 13

9% more capital invested

Capital invested by funds: $43.8M → $47.6M (+$3.83M)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0.54% less ownership

Funds ownership: 13.28% → 12.74% (-0.54%)

16% less funds holding

Funds holding: 49 → 41 (-8)

64% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 11

Holders
41
Holders Change
-8
Holders Change %
-16.33%
% of All Funds
1.02%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
4
Increased
17
Reduced
13
Closed
11
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
NIM
Needham Investment Management
New York
+$714K
2
RJA
Raymond James & Associates
Florida
+$347K
3
Cohen & Steers
Cohen & Steers
New York
+$346K
4
LPL Financial
LPL Financial
California
+$344K
5
FHA
Flagship Harbor Advisors
Massachusetts
+$254K

Top Sellers

1
First Trust Advisors
First Trust Advisors
Illinois
-$952K
2
Citigroup
Citigroup
New York
-$441K
3
AGM
Alpine Global Management
New York
-$437K
4
DA
Doliver Advisors
Texas
-$433K
5
Stifel Financial
Stifel Financial
Missouri
-$308K
Name Holding Trade Value Shares
Change 		Change in
Stake
NIM
1
Needham Investment Management
New York
$11.2M +$714K +38,531 +7%
Morgan Stanley
2
Morgan Stanley
New York
$10.8M -$111K -5,976 -1%
Wells Fargo
3
Wells Fargo
California
$3.7M -$258K -13,951 -7%
FHA
4
Flagship Harbor Advisors
Massachusetts
$3.44M +$254K +13,715 +8%
LPL Financial
5
LPL Financial
California
$2.35M +$344K +18,542 +18%
Citigroup
6
Citigroup
New York
$1.85M -$441K -23,794 -20%
RJA
7
Raymond James & Associates
Florida
$1.85M +$347K +18,735 +24%
UBS Group
8
UBS Group
Switzerland
$1.22M -$134K -7,253 -10%
Bank of Nova Scotia
9
Bank of Nova Scotia
Ontario, Canada
$1.17M -$221K -11,911 -16%
Cohen & Steers
10
Cohen & Steers
New York
$1.16M +$346K +18,694 +46%
LTFS
11
Ladenburg Thalmann Financial Services
Florida
$988K +$11.5K +619 +1%
Cambridge Investment Research Advisors
12
Cambridge Investment Research Advisors
Iowa
$903K +$1.59K +86 +0.2%
Commonwealth Equity Services
13
Commonwealth Equity Services
Massachusetts
$843K -$19.1K -1,031 -2%
CCP
14
Clough Capital Partners
Massachusetts
$825K – – –
Bank of America
15
Bank of America
North Carolina
$621K -$60.8K -3,283 -9%
AG
16
Advisor Group
Arizona
$587K +$39.3K +2,119 +8%
Stifel Financial
17
Stifel Financial
Missouri
$506K -$308K -16,642 -39%
OC
18
Oppenheimer & Co
New York
$499K +$3.11K +168 +0.7%
Royal Bank of Canada
19
Royal Bank of Canada
Ontario, Canada
$335K +$59.9K +3,235 +23%
Ameriprise
20
Ameriprise
Minnesota
$313K +$26.4K +1,427 +10%
Janney Montgomery Scott
21
Janney Montgomery Scott
Pennsylvania
$302K +$50.6K +2,733 +21%
RJFSA
22
Raymond James Financial Services Advisors
Florida
$282K -$46.6K -2,513 -15%
BTS
23
BB&T Securities
Virginia
$267K -$220K -11,850 -46%
Creative Planning
24
Creative Planning
Kansas
$260K -$10.3K -556 -4%
NSAM
25
North Star Asset Management
Wisconsin
$259K – – –
1
2

HQL Hedge Fund Activity: Q1 2017 in Review

41 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in abrdn Life Sciences Investors (HQL) for Q1 2017, worth a combined $47.6M — up 8.7% from $43.8M a quarter earlier.

Sellers outnumbered buyers: 11 funds closed out of HQL and 4 opened new positions — a net loss of 7 holders — while 13 trimmed existing stakes and 17 added.

The largest buyer was Needham Investment Management, adding an estimated $714K. The largest seller was First Trust Advisors, exiting entirely with an estimated $952K sold.

  • 41 institutional investors held abrdn Life Sciences Investors (HQL) as of Q1 2017, down from 49 in Q4 2016.
  • Funds reported $47.6M of abrdn Life Sciences Investors stock for Q1 2017, up 8.7% quarter-over-quarter.
  • 4 funds opened new abrdn Life Sciences Investors positions in Q1 2017 and 11 closed out, a net change of -7 holders.
  • The largest abrdn Life Sciences Investors buyer in Q1 2017 was Needham Investment Management, an estimated $714K added.
  • The largest abrdn Life Sciences Investors seller in Q1 2017 was First Trust Advisors, an estimated $952K sold.

Based on aggregated 13F filings for Q1 2017.